Zensar Technologies has announced the grant of 15,678 stock options to eligible employees under its ‘ESOP 2025’ scheme. Approved by the Nomination and Remuneration Committee on April 30, 2026, this initiative aims to align employee interests with the company’s long-term performance. Each option is convertible into one equity share of the company, with an exercise price set at the face value of ₹2 per share.
Details of the ESOP 2025 Grant
The Nomination and Remuneration Committee of Zensar Technologies has formally approved the allocation of 15,678 options to its workforce. This grant is part of the company’s ‘Zensar – Employees Stock Option Scheme 2025’, designed to incentivize employees across various levels and foster a sense of ownership in the company’s growth and the performance of its unlisted subsidiaries.
Pricing and Vesting Framework
The exercise price for the granted options is fixed at ₹2 per option, which corresponds to the face value of the company’s equity shares. This structure ensures that employees benefit directly from future appreciation in company value. Regarding the exercise window, the scheme stipulates that once vested, options can be exercised either in full or in part within a maximum period of 5 years from the respective date of vesting.
Implementation Strategy
The administration of this scheme is overseen by the Nomination and Remuneration Committee acting as a Compensation Committee. To facilitate this grant, the company utilizes a Trust Route. Under this arrangement, the Zensar Employees Welfare Trust is tasked with acquiring the necessary shares through secondary acquisitions from the open market, ensuring that the issuance does not lead to unnecessary dilution for existing shareholders.
Source: BSE
